Back
Entrada Therapeutics, Inc. Stock Price Chart
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
71
TRDA
Entrada Therapeutics, Inc.
Last Price:
$10.18
Seasonality Move:
-3.5%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight buying pressure.
Entrada Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.04 | Buy |
| 20-day SMA: | 9 | Buy |
| 50-day SMA: | 7.39 | Buy |
| 200-day SMA: | 7.64 | Buy |
| 8-day EMA: | 9.89 | Buy |
| 20-day EMA: | 9.12 | Buy |
| 50-day EMA: | 7.89 | Buy |
| 200-day EMA: | 8.4 | Buy |
Entrada Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 72.4 | Buy |
| Chaikin Money Flow: | 59577 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.25 - 9.89) | Buy |
| Bollinger Bands (100): | (5.07 - 7.95) | Buy |
Entrada Therapeutics, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entrada Therapeutics, Inc. Stock
Is Entrada Therapeutics, Inc. Stock a Buy?
-
Entrada Therapeutics, Inc. share price is 10.16 while TRDA 8-day simple moving average is 10.04, which is a Buy signal.
-
The stock price of TRDA is 10.16 while Entrada Therapeutics, Inc. 20-day SMA is 9.00, which makes it a Buy.
-
Entrada Therapeutics, Inc. 50-day simple moving average is 7.39 while TRDA share price is 10.16, making it a Buy technically.
-
TRDA stock price is 10.16 and Entrada Therapeutics, Inc. 200-day simple moving average is 7.64, creating a Buy signal.
TRDA Technical Analysis vs Fundamental Analysis
Buy
71
Entrada Therapeutics, Inc. (TRDA)
is a Buy
Is Entrada Therapeutics, Inc. a Buy or a Sell?
-
Entrada Therapeutics, Inc. stock is rated a BuyThe current Entrada Therapeutics, Inc. [TRDA] share price is $10.16. The Score for TRDA is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Entrada Therapeutics, Inc. Stock Info
Market Cap:
388.3M
Price in USD:
10.16
Share Volume:
123.9K
Entrada Therapeutics, Inc. 52-Week Range
52-Week High:
21.79
52-Week Low:
4.93
Buy
71
Entrada Therapeutics, Inc. (TRDA)
is a Buy
Entrada Therapeutics, Inc. Share Price Forecast
-
What is the Entrada Therapeutics, Inc. stock price today?The Entrada Therapeutics, Inc. stock price is 10.16 USD today.
-
Will TRDA stock go up or go down?Entrada Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Entrada Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics, Inc. is not overvalued.
Is Entrada Therapeutics, Inc. Stock a Buy?
-
Entrada Therapeutics, Inc. share price is 10.16 while TRDA 8-day exponential moving average is 9.89, which is a Buy signal.
-
The stock price of TRDA is 10.16 while Entrada Therapeutics, Inc. 20-day EMA is 9.12, which makes it a Buy.
-
Entrada Therapeutics, Inc. 50-day exponential moving average is 7.89 while TRDA share price is 10.16, making it a Buy technically.
-
TRDA stock price is 10.16 and Entrada Therapeutics, Inc. 200-day simple moving average is 8.40, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics, Inc.
Is Entrada Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.44 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Entrada Therapeutics, Inc.
Should I short Entrada Therapeutics, Inc. stock?
-
TRDA Moving Average Covergence Divergence (MACD) indicator is 0.86, suggesting Entrada Therapeutics, Inc. is a Buy
-
Entrada Therapeutics, Inc. Relative Strength Index (RSI) is 72.4, which suggest Entrada Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Entrada Therapeutics, Inc. is (7.25 - 9.89), which suggest Entrada Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Entrada Therapeutics, Inc. is (5.07 - 7.95), which suggest Entrada Therapeutics, Inc. is a Buy
* Entrada Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.